PhaseBio Pharmaceuticals EPS (Basic, from Continuous Ops)

EPS (Basic, from Continuous Ops) of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Basic, from Continuous Ops) growth rates and interactive chart.


Highlights and Quick Summary

  • EPS (Basic, from Continuous Ops) for the quarter ending March 31, 2022 was -0.23 (a -72.97% decrease compared to previous quarter)
  • Year-over-year quarterly EPS (Basic, from Continuous Ops) decreased by -61.67%
  • Annual EPS (Basic, from Continuous Ops) for 2021 was -2.98 (a -12.02% decrease from previous year)
  • Annual EPS (Basic, from Continuous Ops) for 2020 was -3.39 (a 137.63% increase from previous year)
  • Annual EPS (Basic, from Continuous Ops) for 2019 was -1.43 (a -68.24% decrease from previous year)
  • Twelve month EPS (Basic, from Continuous Ops) ending March 31, 2022 was -2.34 (a -21.63% decrease compared to previous quarter)
  • Twelve month trailing EPS (Basic, from Continuous Ops) decreased by -30.58% year-over-year
Trailing EPS (Basic, from Continuous Ops) for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
-2.34 -2.98 -3.17 -3.37
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Basic, from Continuous Ops) of PhaseBio Pharmaceuticals

Most recent EPS (Basic, from Continuous Ops)of PHAS including historical data for past 10 years.

Interactive Chart of EPS (Basic, from Continuous Ops) of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals EPS (Basic, from Continuous Ops) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 -0.23
2021 -0.85 -0.66 -0.6 -0.87 -2.98
2020 -1.04 -0.86 -0.98 -0.52 -3.39
2019 -0.4 -0.4 -0.33 -0.3 -1.43
2018 20.8 -10.45 -8.95 -5.9 -4.5
2017 -3.45 -13.79

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology